Matthew Hong

Flinders University — Australia

Medicine · Health Sciences

25h-index2.3kcitations99works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(32), Prostate Cancer Diagnosis and Treatment(19), Hormonal and reproductive studies(6), Urologic and reproductive health conditions(6), Bladder and Urothelial Cancer Treatments(5)

Publications94 total

<scp>BCG</scp> Intolerance in Nonmuscle Invasive Bladder Cancer—A Systematic Review
ANZ Journal of Surgery·2025· 3 citedOpen Access
HAND Me the Data: Fast Robot Adaptation via Hand Path Retrieval
arXiv (Cornell University)·2025Open Access
CLAM: Continuous Latent Action Models for Robot Learning from Unlabeled Demonstrations
arXiv (Cornell University)·2025Open Access
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study
Clinical Infectious Diseases·2024· 3 citedOpen Access
Stylish and Functional: Guided Interpolation Subject to Physical Constraints
arXiv (Cornell University)·2024Open Access
Pharmacological Inhibition of Astrocytic Transglutaminase 2 Facilitates the Expression of a Neurosupportive Astrocyte Reactive Phenotype in Association with Increased Histone Acetylation
Biomolecules·2024· 2 citedOpen Access
Genitourethral foreign bodies: 20-year experience and outcomes from a single center
Asian Journal of Andrology·2024· 6 citedOpen Access
Understanding the Cognitive Complexity in Language Elicited by Product Images
arXiv (Cornell University)·2024Open Access
Genitourinary Foreign Bodies – A single-centre case series and outcomes
Australian and New Zealand Continence Journal·2024Open Access
Genitourinary Foreign Bodies – A single-centre case series and outcomes
Australian and New Zealand Continence Journal·2024Open Access
Pharmacological inhibition of astrocytic transglutaminase 2 facilitates the expression of a neurosupportive astrocyte reactive phenotype in association with increased histone acetylation
2024· 1 citedOpen Access
BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies
Frontiers in Neuroscience·2024· 12 citedOpen Access
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension
JAMA·2023· 161 citedOpen Access
Anticipatory thinking in design
AI Magazine·2023· 1 citedOpen Access
Data from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Data from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Figure 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Figure 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Table 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Table 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Niall M. Corcoran(22), Christopher M. Hovens(19), Anthony J. Costello(18), Justin S. Peters(12), Lauren Wilcox(9), Geoff Macintyre(7), John Pedersen(7), Laurence Harewood(6), Nikhil Sapre(5), Michael Kerger(5), John S. Pedersen(5), Anthony J. Ryan(5), Marek Cmero(4), Stefano Mangiola(4), Natalie J. Kurganovs(4), Rowan G. Casey(4), S. Larry Goldenberg(4), Martin Gleave(4), Thomas A. Olson(4), Izhak Haviv(3)